Omalizumab as a therapeutic option for nasal polyposis in moderate to severe persistent allergic asthma: evidence from a prospective study in a real-world setting.

Omalizumab as a therapeutic option for nasal polyposis in moderate to severe persistent allergic asthma: evidence from a prospective study in a real-world setting. J Investig Allergol Clin Immunol. 2020 Jun 03;:0 Authors: Ruiz-Hornillos J, Rodríguez Jiménez B, Feliu Vila A, Moreno Fernández A, Hernández García MJ, Domínguez-Ortega J, on behalf the ESPLORA group PMID: 32490823 [PubMed - as supplied by publisher]
Source: Journal of Investigational Allergology and Clinical Immunology - Category: Allergy & Immunology Authors: Tags: J Investig Allergol Clin Immunol Source Type: research